HPV and Cervical Cancer Screening and Prevention - PowerPoint PPT Presentation

1 / 11
About This Presentation
Title:

HPV and Cervical Cancer Screening and Prevention

Description:

HPV and Cervical Cancer Screening and Prevention Screening Options Traditional Pap Test Liquid-Based Pap Test HPV DNA Test Traditional Pap Test For a Pap test, a ... – PowerPoint PPT presentation

Number of Views:849
Avg rating:3.0/5.0
Slides: 12
Provided by: RebeccaSic4
Category:

less

Transcript and Presenter's Notes

Title: HPV and Cervical Cancer Screening and Prevention


1
  • HPV and Cervical Cancer Screening and Prevention

2
Screening Options
  • Traditional Pap Test
  • Liquid-Based Pap Test
  • HPV DNA Test

3
Traditional Pap Test
  • For a Pap test, a medical practitioner scrapes a
    sample of cells from the cervix.
  • The cervical cells are smeared on a glass slide
    and examined under a microscope.
  • Medical personnel look for abnormalities in the
    cervical cells that could progress to cancer.

4
Liquid-Based Pap Test
  • In liquid-based cytology cervical cells are
    placed in liquid in a small bottle. Some of the
    liquid is placed on a slide and then examined
    under a microscope for abnormalities.
  • Research has shown liquid-based Pap tests to be
    more accurate than the conventional method
    because blood and mucous are removed, making the
    cells easier to see.
  • Liquid-based Pap tests are more expensive and may
    not be available at all clinics.

5
The HPV DNA Test
  • The HPV DNA test checks directly for high-risk
    HPV.
  • HPV testing is FDA-approved in conjunction with a
    Pap test for women age 30 and older and for women
    of all ages as a follow-up to inconclusive Pap
    test results.
  • For women over 30, an HPV test in conjunction
    with a Pap test is more accurate than the Pap
    test alone at identifying women with cervical
    cancer or its early signs.
  • Women under 30 should not get the HPV test with
    the Pap test unless they receive abnormal Pap
    test results. Young women have more frequent HPV
    infections, which usually clear without medical
    action.

6
Screening Guidelines
  • Begin cervical cancer screening 3 years after the
    initiation of sexual intercourse, or by age 21
    (whichever comes first).
  • Women should be screened annually with a regular
    Pap test or every 1-2 years with a liquid-based
    Pap test. All women under 30 should be screened
    for cervical cancer at least every two years.
  • Women age 30 and older with 3 normal Pap tests in
    a row should discuss the recommended frequency of
    cervical cancer screening with their doctor.
  • Women who had a hysterectomy may still need to be
    screened regularly, depending on the type of
    hysterectomy they had. They should discuss their
    situation with their doctor.

7
HPV Test Results and Guidelines
  • For women age 30 and older
  • If both the Pap and HPV tests are negative
    (normal) Get tested again in 3 years.
  • If the Pap test is negative and the HPV test is
    positive
    Repeat the
    Pap test and HPV test in 6 to 12 months to see if
    the virus has cleared. If the virus is still
    present, talk to your doctor about the next
    steps.
  • Both tests are positive
    Talk with your
    doctor about what to do next.

8
Prevention HPV Vaccine
  • In June 2006, the FDA approved the Gardasil
    vaccine for protection against HPV types 16 and
    18, which cause 70 percent of cervical cancers,
    and types 6 and 11, which are responsible for 90
    percent of genital warts.
  • A second HPV vaccine, Cervarix, is completing
    clinical trials. The release of trial results is
    expected in 2009. This vaccine protects against
    types 16 and 18.
  • The availability of an HPV vaccine marks a
    tremendous milestone in the effort to prevent and
    ultimately eliminate, cervical cancer.

9
Who should receive HPV vaccines?
  • To maximize effectiveness, an HPV vaccine should
    be administered before a person becomes sexually
    active.
  • The FDA approved Gardasil for girls and women
    aged 9-26.
  • The Federal Advisory Committee on Immunization
    Practices (ACIP) recommends that Gardasil be
    given routinely to females aged 11 to 12.
    However, the vaccine can be administered to girls
    as young as 9 and to women aged 13 to 26 who have
    not already received the HPV vaccine.
  • Research on vaccinating women over 26 and men is
    underway look for the results in the coming
    months!

10
Are the vaccines safe?
  • In June 2007, WHOs Global Advisory Committee on
    Vaccine Safety (GACVS) concluded that both
    vaccines had good safety profiles.
  • Redness and tenderness at the vaccination site,
    along with low-grade fevers are the most common
    side effects for both vaccines. WHO recommends
    observation for 15 minutes following Gardasil
    vaccination due to reports of dizziness and
    fainting.
  • The vaccines are not recommended for women who
    are pregnant.

11
With the HPV vaccine, is screening still
necessary?
  • Yes! HPV vaccines should be part of a
    comprehensive strategy to eliminate cervical
    cancer.
  • Screening will still be needed to target cervical
    cancers caused by HPV types not covered by the
    vaccine and for women who have already been
    exposed to HPV types 16 and 18.
  • In regions where cervical cancer screening is not
    possible, vaccination is the best way to protect
    the next generation of women from cervical cancer.
Write a Comment
User Comments (0)
About PowerShow.com